Series A funding round for Oyster Point Pharmaceuticals raising $22M in November 2017
Series A funding round for Oyster Point Pharmaceuticals raising $22M in November 2017
| Investor | Firm Type |
|---|
| Partner |
|---|
| Venture Capital | — | |
Versant VenturesLEAD | Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$115M
Top Valuation
-
Oyster Point Pharmaceuticals raised $22M in a Series A round.
The round was announced on 11/01/17.
The round was led by Versant Ventures, Ali Behbahani.